Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did 😎Read how

Regeneron Pharmaceuticals Inc (REGN)

NASDAQ
Currency in USD
Disclaimer
975.74
+7.74(+0.80%)
Real-time Data

REGN Comments

Great for long term. Buy
650 and beyond if their antigen vaccine shows Supreme efficacy.
run away
through the roof
Antigen Vaccine showing promise against CoronaVirus. Over $600 it wént.
REGN will go up to around $581 by June 10th and possibility of over $600 if/when a vaccine for COVID-19 is good to go
Bought today of the pullback buy but earnings are tomorrow
head and shoulders
Troy, if it was a true head and shoulders, why did it continue going up?  If it was an inverse H&S it should have gone up correct?  I am relatively new to this, so bear with me :)
REGN is a leading company to benefit from covid vaccine news.
Why not at ATH????
will wait for 420 to increase my position
target 520
480 coming don't miss
its coming and its from the weekly graph. From the serious investors. I don`t bear any responsibility for any trading losses you might incur as a result of using this data .
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.